-
IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference
-
IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference
-
Why IGM Biosciences (IGMS) Stock Crashed 30% Today
-
IGM Biosciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference
-
IGM Biosciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference
-
UPDATE: RBC Capital Starts IGM Biosciences (IGMS) at Outperform
-
IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
IGM Biosciences Inc. (IGMS) Prices Upsized Offering for Gross Proceeds of Approx. $200M
-
IGM Announces Pricing of Upsized $200 million Public Offering
-
IGM Announces Pricing of Upsized $200 million Public Offering
-
IGM Biosciences Inc. (IGMS) Announces Proposed $150M Public Offering
-
IGM Announces Proposed Public Offering
-
IGM Announces Proposed Public Offering
-
IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference
-
IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference

